How are marketable securities typically reported in healthcare financial statements?

Marketable securities in healthcare financial statements are typically reported at fair value. This approach aligns with the requirements of Accounting Standards Codification (ASC) Topic 320, which states that marketable securities, such as stocks and bonds that can be easily sold in the market, should be measured at their current market price.

Reporting at fair value provides a more accurate representation of the investment's worth at the reporting date and reflects the current economic conditions. This is particularly important in the healthcare sector, where entities often hold these types of securities for liquidity purposes and to fund operational needs or capital projects.

Options such as historical cost, amortized cost, or estimated market value do not align with the standard practice for reporting marketable securities, as they do not provide a real-time view of the assets' financial standing. Historical cost represents the original purchase price and does not account for fluctuations in market value, while amortized cost is generally used for certain debt securities held to maturity and would not apply to typical marketable securities held for trading. Estimated market value lacks the precision and regulatory acceptance of fair value as defined in accounting standards.